Cero Therapeutics
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
Cero Therapeutics is a company in biotechnology, therapeutics based in San Francisco Bay Area, West Coast, Western US, founded in 2017.
Within the biotechnology, therapeutics space, the company focuses on its core offering rather than a broad product line.
Its base of operations is San Francisco Bay Area, West Coast, Western US.
The company is listed at the Series_A stage of development.
The company reports a headcount in the c_00001_00010 range.
Public records show total funding of about $41.4M.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Country | US |
| Founded | 2017 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $41,399,999 |
Website: www.cero.bio
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account